Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Blood|July 12, 2013
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registryMartin Höglund, Fredrik Sandin, Karin Hellström, et al.
Leukemia|January 26, 2024
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trialHjalmar Flygt, Stina Söderlund, Johan Richter, et al.
European Journal of Haematology|August 2, 2014
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)Henrik Hjorth-Hansen, Leif Stenke, Stina Söderlund, et al.
Experimental Hematology|July 31, 2012
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemiaAnna Kreutzman, Taina Jaatinen, Dario Greco, et al.
British Journal of Haematology|August 16, 2002
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemiaHelene Hallböök, Bengt Simonsson, Thomas Ahlgren, et al.
Disaster Medicine and Public Health Preparedness|October 12, 2011
First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiationNicholas Dainiak, Robert Nicolas Gent, Zhanat Carr, et al.
Disaster Medicine and Public Health Preparedness|October 12, 2011
Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systemsNicholas Dainiak, Robert Nicolas Gent, Zhanat Carr, et al.
Leukemia & Lymphoma|October 27, 2006
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phaseUlla Olsson-Strömberg, Martin Höglund, Magnus Björkholm, et al.
The Journal of Clinical Investigation|September 1, 2022
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemiaJani Huuhtanen, Mette Ilander, Bhagwan Yadav, et al.
Acta Haematologica|May 5, 2005
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-upBengt Simonsson, Gunnar Oberg, Mats Bjoreman, et al.
Pageof 7